Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis

por Kao, Hsiang-Fong, Liao, Bin-Chi, Huang, Yen-Lin, Huang, Huai-Cheng, Chen, Chun-Nan, Chen, Tseng-Cheng, Hong, Yuan-Jing, Chan, Ching-Yi, Chia, Jean-San, Hong, Ruey-Long
Publicado 2022